HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates MiMedx Group (NASDAQ:MDXG) with a Buy and maintains $8 price target.
What’s Going On With Elevation Oncology Stock?
Elevation Oncology, Inc. (NASDAQ: ELEV) shares raced higher Monday. The company announced program updates and upcoming 2024 milestones on Friday.